(FFEB) FT Cboe Vest U.S. Equity - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US33740F7630
FFEB: FLEX Options, Customized Contracts, S&P 500, ETF
The FT Cboe Vest U.S. Equity Buffer ETF - February (BATS:FFEB) is an exchange-traded fund that employs a unique investment strategy, utilizing FLexible EXchange Options (FLEX Options) to track the performance of the SPDR S&P 500 ETF Trust. By doing so, the fund provides investors with a customizable equity or index option contract that allows for tailored exercise prices, styles, and expiration dates, offering a degree of flexibility in its investment approach.
The fund is categorized under Defined Outcome ETFs, indicating that it is designed to provide a specific investment outcome, likely with a focus on risk management. As a non-diversified fund, FFEB may concentrate its investments in a limited number of securities or options, which can result in higher volatility. The funds underlying investment in FLEX Options referencing the SPDR S&P 500 ETF Trust implies that its performance is closely tied to the S&P 500 index.
Analyzing the available data, it is evident that the fund has experienced a relatively stable price movement, with a current price of $51.10. The short-term and long-term moving averages (SMA20: $50.90, SMA50: $49.36, SMA200: $49.37) suggest a positive trend, indicating that the fund has been consistently rising over the past few months. The Average True Range (ATR) of 0.37, equivalent to 0.73%, implies a moderate level of volatility.
Based on the available technical and fundamental data, a forecast for FFEB can be constructed. The funds AUM of $1.015 billion and its stable price movement suggest a relatively stable and liquid investment. Considering the current price is near its 52-week high ($51.50), and the SMA20 is above the SMA50 and SMA200, a potential short-term target could be $52.00. However, the ATR and the current price level suggest that the upside may be limited, and a potential correction or consolidation phase may be imminent. Therefore, a conservative estimate for the next few weeks could be a slight increase, potentially reaching $51.50, followed by a potential pullback to $50.50. A more detailed analysis of the underlying FLEX Options and the SPDR S&P 500 ETF Trust would be required to refine this forecast.
Additional Sources for FFEB ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
FFEB ETF Overview
Market Cap in USD | 1,046m |
Category | Defined Outcome |
TER | 0.85% |
IPO / Inception | 2020-02-21 |
FFEB ETF Ratings
Growth Rating | 77.0 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -2.57 |
Analysts | - |
Fair Price Momentum | 51.16 USD |
Fair Price DCF | - |
FFEB Dividends
Currently no dividends paidFFEB Growth Ratios
Growth Correlation 3m | 92.2% |
Growth Correlation 12m | 65.2% |
Growth Correlation 5y | 90.6% |
CAGR 5y | 12.47% |
CAGR/Max DD 5y | 0.90 |
Sharpe Ratio 12m | 1.21 |
Alpha | 1.43 |
Beta | 0.585 |
Volatility | 7.44% |
Current Volume | 7.9k |
Average Volume 20d | 14.9k |
As of June 30, 2025, the stock is trading at USD 52.19 with a total of 7,879 shares traded.
Over the past week, the price has changed by +1.44%, over one month by +2.96%, over three months by +6.97% and over the past year by +11.23%.
Yes. Based on ValueRay´s Analyses, FT Cboe Vest U.S. Equity (BATS:FFEB) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 77.00 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FFEB is around 51.16 USD . This means that FFEB is currently overvalued and has a potential downside of -1.97%.
FT Cboe Vest U.S. Equity has no consensus analysts rating.
According to our own proprietary Forecast Model, FFEB FT Cboe Vest U.S. Equity will be worth about 57.7 in June 2026. The stock is currently trading at 52.19. This means that the stock has a potential upside of +10.48%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 57.7 | 10.5% |